Beyond HRD status: Comprehensive Molecular Characterization of Advanced Epithelial Ovarian Cancer

ABSTRACT: Molecular characterization of patients enrolled in a clinical phase II study in relapsed ovarian cancer

INSTRUMENT(S): Illumina NovaSeq 6000

ORGANISM(S): Homo Sapiens

SUBMITTER: Center for Genomic Medicine, Rigshospitalet 

PROVIDER: PRJEB82346 | EVA | 2024-11-11

REPOSITORIES: EVA